Skip to main content
Clinical Trials/NCT03166592
NCT03166592UnknownNot Applicable

Impact of Advanced Neuroimaging Techniques in Evaluation of Intra Axial Brain Masses Based on Magnetic Resonance Diagnostic Strategy in Adults

Assiut University2 sites in 1 country150 target enrollmentStarted: July 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
150
Locations
2
Primary Endpoint
Number of patients with malignant masses

Study Overview

Brief Summary

Although the Magnetic resonance imaging with contrast is the gold standard for diagnosis of intra axial brain masses. The conventional Magnetic resonance imaging appearances of intra axial brain masses can be non-specific and even the use of contrast agent is of limited benefit.

Contrast enhancement reflects only disruption of blood brain barrier. One third of high-grade malignancies are non-enhanced and may non-neoplastic lesions show contrast enhancement.

Reliable differentiation of neoplastic from non-neoplastic brain masses, or of high grade from low grade tumor, is difficult with conventional Magnetic resonance imaging

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of patients with malignant masses

Time Frame: 1 hour

sensitivity of the magnetic resonance spectroscopy in diagnosis of brain malignant masses

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Mohamed Abbas

principal investigator

Assiut University

Study Sites (2)

Loading locations...

Similar Trials